Epic Sciences Raises $30M For Cancer Diagnostics

San Diego-based Epic Sciences, a biotech startup focusing on diagnostics for treatment and management of cancer, has raised $30M in a Series C funding. The funding came from RusnanoMedInvest (RMI) and Arcus Ventures, plus Domain Associates, Roche Venture Fund, and Pfizer Venture Investments, as well as angels. According to the company, the financing will go towards commercialization efforts. The company said its technology focuses on tracking the proteomic and genomic changes that occur over time during the treatment of a patient's cancer, from a minimally invasive liquid biopsy. More information »